Biotech giant Amgen is putting up the money to fund three research projects in partnership with the University of Washington’s Institute for Protein Design (IPD). Amgen declined to disclose the… Read More
Carlos Campoy is the new CFO at Alder BioPharmaceuticals. The Bothell, Wash.-based drug company is developing eptinezumab, an antibody-based migraine treatment that’s currently undergoing a pivotal phase 3 trial. Campoy… Read More